BioSpace News Archive

Telemedicine Offers an Alternative to Healthcare Services for Non-Emergent Routine Illnesses

10-minute test for coronavirus exposure utilizing blood from a finger prick can be performed anywhere by trained professionals, e.g. airports, schools, work, doctor’s office

Hagens Berman urges RTI Surgical Holdings, Inc. investors who have suffered significant losses to submit their loss now.

Yokogawa Electric Corporation announces that it has developed the SU10 Single CellomeTM Unit, a device that uses a nanopipette*1 to inject substances such as genes and drugs and aspirate intracellular materials at target locations in individual cells.

Quidel Corporation announced that Quidel has received Emergency Use Authorization from the U.S. Food and Drug Administration to market its Lyra® SARS-CoV-2 Assay, a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal or oropharyngeal swab specimens from patients suspected of COVID-19 by their healthcare provider.

Cigna Corporation announced the results as of 5:00 p.m., New York City time, on March 17, 2020 of its previously announced offers to purchase for cash up to $500,000,000 of Cigna Holding Company’s 4.000% Senior Notes due 2022